The early spread of HIV-2 in Western Africa is imperfectly described for group B and the recently identified subtype A2. Recent HIV-2 epidemiological data are also scarce outside of Guinea-Bissau. The sequence database of the HIV-2 ANRS CO5-cohort, one of the largest to date, was used to explore the early migration patterns of these strains by phylodynamic's means. All publicly available (forty-nine and eight for A and B, respectively) and ANRS CO5-cohort (125 and 68 for A and B, respectively) pol sequences with available time of sampling and patient's country of birth were included. Bayesian phylogeographic reconstructions and effective population size estimations were performed under the best fitting combination of evolutionary, demographic, and molecular clock models using BEAST 1.8. The tree topology was assessed with maximum likelihood trees using RAxML 8.0.0. The estimated introduction of group A in humans was 1945 \[95 per cent HPD: 1935--1953\], as previously reported. Subtype A1, present in Senegal, Gambia, Guinea-Bissau, and Guinea, experienced an early diversification around 1946 \[1936--1954\] with two distinct early epidemics in Guinea-Bissau and Senegal. Subtype A2, present in Ivory Coast and Mali, experienced a latter diversification (1956 \[1947--1963\]) in Ivory Coast with two introduction events in Mali (1963 \[1957--1969\] and 1967 \[1960--1974\]). Group B was originally introduced in Ivory Coast in 1962 \[1953--1913\]. Changes in effective population size over time revealed initial exponential growth phases occurring sequentially for the three HIV-2 strains and followed by a population decline starting in the 2000s for all HIV-2 strains. The rate of this decline was slower for A2 and B subtypes (Ivory Coast, Mali) than for A1 (Guinea-Bissau, Senegal). This phylogeographic study is the first to reconstruct the early dispersal of A2 and B HIV-2 clades in Western Africa. Our results suggest that subtype A1 was circulating in Guinea-Bissau and Senegal before the independence war of the former, believed to have contributed to the dispersal of HIV-2. Both A2 and B clades emerged in Ivory Coast and experienced latter diversification and population expansion (starting in 1980 and 1990, respectively) than A1. There is indication of slow decreasing incidence rates of HIV-2 in Ivory Coast or Mali where recent data are scarce.
